Common eligibility criteria may include: BMI of 30 or higher BMI of 27 or higher with at least one weight-related health condition History of failed diet attempts or weight regain Appetite, cravings, or portion control challenges Metabolic risk factors such as insulin resistance, elevated glucose, high cholesterol, or hypertension Need for physician-supervised weight loss due to medical complexity Eligibility must be determined through a medical consultation
hdl:10773/24632
The lead authors of the study are Mahesh Umapathysivam, MBBS, DPhil, an endocrinologist and clinical researcher at Adelaide University in Australia and a former trainee with Gloyn, and Elisa Araldi, PhD, associate professor of medicine and surgery at the University of Parma in Italy and a former trainee with Stoffel
However, retatrutide has not yet received marketing authorisation from the MHRA or EMA, meaning it is not currently available as a licensed medicine in the UK
Hair loss is something that many people experience at some point in their life, and it can feel frustrating when youre looking for ways to treat it
Pregnant people who are taking these medications for weight loss can safely discontinue the medication under their healthcare providers supervision
